Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia

Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia

Abstract Background Invasive candidiasis and/or candidemia (IC/C) is a common fungal infection leading to significant health and economic losses worldwide. Caspofungin was shown to be more effective than fluconazole in treating inpatients with IC/C. However, cost-effectiveness of caspofungin for tre...

Full description

Bibliographic Details
Main Authors: Gebremedhin Beedemariam Gebretekle, Atalay Mulu Fentie, Girma Tekle Gebremariam, Eskinder Eshetu Ali, Daniel Asfaw Erku, Tinsae Alemayehu, Workeabeba Abebe, Beate Sander
Format: Article
Language:English
Published: BMC 2022-10-01
Series:BMC Health Services Research
Subjects:
Candidemia
Caspofungin
Echinocandin
Fluconazole
Invasive candidiasis
Cost-effectiveness
Online Access:https://doi.org/10.1186/s12913-022-08662-3

Internet

https://doi.org/10.1186/s12913-022-08662-3

Similar Items